Webbläsaren som du använder stöds inte av denna webbplats. Alla versioner av Internet Explorer stöds inte längre, av oss eller Microsoft (läs mer här: * https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Var god och använd en modern webbläsare för att ta del av denna webbplats, som t.ex. nyaste versioner av Edge, Chrome, Firefox eller Safari osv.

Mitochondrial DNA copy number and future risk of B-cell lymphoma in a nested case-control study in the prospective EPIC cohort.

Författare

  • Fatemeh Saberi Hosnijeh
  • Qing Lan
  • Nathaniel Rothman
  • Chin San Liu
  • Wen-Ling Cheng
  • Alexandra Nieters
  • Per Guldberg
  • Anne Tjønneland
  • Daniele Campa
  • Alessandro Martino
  • Heiner Boeing
  • Antonia Trichopoulou
  • Pagona Lagiou
  • Dimitrios Trichopoulos
  • Vittorio Krogh
  • Rosario Tumino
  • Salvatore Panico
  • Giovanna Masala
  • Elisabete Weiderpass
  • José María Huerta Castaño
  • Eva Ardanaz
  • Núria Sala
  • Miren Dorronsoro
  • J Ramón Quirós
  • María-José Sánchez
  • Beatrice Melin
  • Ann Sofie Johansson
  • Johan Malm
  • Signe Borgquist
  • Petra H Peeters
  • H Bas Bueno-de-Mesquita
  • Nick Wareham
  • Kay-Tee Khaw
  • Ruth C Travis
  • Paul Brennan
  • Afshan Siddiq
  • Elio Riboli
  • Paolo Vineis
  • Roel Vermeulen

Summary, in English

It has been suggested that mitochondrial dysfunction and DNA damage are involved in lymphomagenesis. Increased copy number of mitochondrial DNA (mtDNA) as a compensatory mechanism of mitochondrial dysfunction previously has been associated with B-cell lymphomas, in particular chronic lymphocytic leukemia (CLL). However, current evidence is limited and based on a relatively small number of cases. Using a nested case-control study, we extended these findings with a focus on subtype specific analyses. Relative mtDNA copy number was measured in the buffy coat of prospectively collected blood of 469 lymphoma cases and 469 matched controls. The association between mtDNA copy number and the risk of developing lymphoma and histologic subtypes was examined using logistic regression models. We found no overall association between mtDNA and risk of lymphoma. Subtype analyses revealed, significant increased risks of CLL (n=102) with increasing mtDNA copy number (OR=1.34, 1.44 and 1.80 for quartiles 2-4, respectively P-trend=0.001). mtDNA copy number was not associated with follow-up time suggesting that this observation is not strongly influenced by indolent disease status. This study substantially strengthens the evidence that mtDNA copy number is related to risk of CLL and supports the importance of mitochondrial dysfunction as a possible mechanistic pathway in CLL ontogenesis.

Avdelning/ar

Publiceringsår

2014

Språk

Engelska

Sidor

530-535

Publikation/Tidskrift/Serie

Blood

Volym

124

Issue

4

Dokumenttyp

Artikel i tidskrift

Förlag

American Society of Hematology

Ämne

  • Hematology

Status

Published

Forskningsgrupp

  • Clinical Chemistry, Malmö

ISBN/ISSN/Övrigt

  • ISSN: 1528-0020